Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.

Antimicrobial Agents and Chemotherapy
Heather J AdamCanadian Nosocomial Infection Surveillance Program

Abstract

We describe the epidemiology of heterogeneously resistant Staphylococcus aureus (hVISA) identified in Canadian hospitals between 1995 and 2006. hVISA isolates were confirmed by the population analysis profiling-area under the curve method. Only 25 hVISA isolates (1.3% of all isolates) were detected. hVISA isolates were more likely to have been health care associated (odds ratio [OR], 5.1; 95% confidence interval [CI], 1.9 to 14.2) and to have been recovered from patients hospitalized in central Canada (OR, 3.0; 95% CI, 1.2 to 7.4). There has been no evidence of vancomycin "MIC creep" in Canadian strains of methicillin (meticillin)-resistant S. aureus, and hVISA strains are currently uncommon.

References

Sep 28, 2001·Journal of Clinical Microbiology·M R MulveyUNKNOWN Canadian Committee for the Standardization of Molecular Methods
Mar 2, 2002·The Lancet Infectious Diseases·K Hiramatsu
Aug 27, 2002·The Journal of Infectious Diseases·Andrew E SimorUNKNOWN Canadian Hospital Epidemiology Committee and Canadian Nosocomial Infection Surveillance Program, Health Canada
Jan 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patrick G P CharlesM Lindsay Grayson
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amir KhosrovanehRiad Khatib
May 6, 2005·Journal of Clinical Microbiology·Nottasorn PlipatRichard B Thomson
Nov 16, 2005·The Journal of Antimicrobial Chemotherapy·Fabien GarnierMarie-Cécile Ploy
Nov 6, 2007·American Journal of Infection Control·Marianna Ofner-AgostiniDenise Gravel
Jun 17, 2008·The Journal of Antimicrobial Chemotherapy·Juan-Ignacio AlósFrancisco Rodríguez-Salvanés
Jan 13, 2009·The Journal of Antimicrobial Chemotherapy·Steven N LeonardMichael J Rybak

❮ Previous
Next ❯

Citations

Mar 21, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sebastiaan J van Hal, Vance G Fowler
Aug 18, 2012·The Journal of Antimicrobial Chemotherapy·R ReynoldsUNKNOWN BSAC Extended Working Party on Resistance Surveillance
Apr 23, 2013·The Journal of Antimicrobial Chemotherapy·Kimberly A NicholUNKNOWN Canadian Antimicrobial Resistance Alliance
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Sebastiaan J van Hal, David L Paterson
Mar 17, 2010·Antimicrobial Agents and Chemotherapy·Andrew E SimorUNKNOWN Canadian Nosocomial Infection Surveillance Program
Dec 3, 2014·The Surgical Clinics of North America·Pang Y Young, Rachel G Khadaroo
Nov 4, 2011·International Journal of Antimicrobial Agents·Marco FalconeMario Venditti
Mar 1, 2011·Diagnostic Microbiology and Infectious Disease·Kimberly A NicholUNKNOWN Canadian Antimicrobial Resistance Alliance (CARA)
Jul 30, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideaki HanakiYoshihito Niki
Jun 8, 2014·Diagnostic Microbiology and Infectious Disease·Alessandro Conrado de Oliveira SilveiraPedro Alves d'Azevedo
Jan 21, 2015·Diagnostic Microbiology and Infectious Disease·Shih-Cheng ChangJang-Jih Lu
Jul 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andre C KalilJan L Brozek
Jan 9, 2015·Clinical Microbiology Reviews·Omar M El-Halfawy, Miguel A Valvano
Jul 2, 2010·Current Opinion in Infectious Diseases·Winfried V Kern
Sep 15, 2010·Drugs·Ioanna EleftheriadouAndrew J Boulton
Jun 21, 2020·The Journal of Antimicrobial Chemotherapy·Betsy E CastroLorena Diaz
Mar 7, 2021·The Journal of Antimicrobial Chemotherapy·Sarah C J JorgensenBruce R Dalton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.